Open AccessMicropuncture closure following high density microarray patch application in healthy subjects
Author(s) -
Henricson Joakim,
Muller David A.,
Baker S. Ben,
Iredahl Fredrik,
Togö Totte,
Anderson Chris D.
Publication year - 2022
Publication title -
skin research and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.521
H-Index - 69
eISSN - 1600-0846
pISSN - 0909-752X
DOI - 10.1111/srt.13131
Subject(s) - transepidermal water loss , histamine , adjuvant , atopic dermatitis , vaccination , medicine , skin reaction , barrier function , basal (medicine) , erythema , immunology , biology , pathology , stratum corneum , insulin , microbiology and biotechnology
Background The high‐density microarray patch (HD‐MAP) promises to be a robust vaccination platform with clear advantages for future global societal demands for health care management. The method of action has its base not only in efficient delivery of vaccine but also in the reliable induction of a local innate physical inflammatory response to adjuvant the vaccination process. The application process needs to induce levels of reactivity, which are acceptable to the vaccine, and from which the skin promptly recovers. Materials and methods 1 × 1 cm HD‐MAP patches containing 5000, 250‐μm long microprojections were applied to the skin in 12 healthy volunteers. The return of skin barrier function was assessed by transepidermal water loss (TEWL) and reaction to topical histamine challenge. Results Skin barrier recovery by 48 h was confirmed for all HD‐MAP sites by recovered resistance to the effects of topical histamine application. Conclusions Our previous observation, that the barrier disruption indicator TEWL returns to normal by 48 h, is supported by this paper's demonstration of return of skin resistance to topical histamine challenge in twelve healthy subjects.